Azathioprine - Inflammatory bowel disease

You are here : Home > Formulary Search > Azathioprine - Inflammatory bowel disease

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Amber

Formulations :

Oral suspension
Tablets

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

Guidelines

SPC

Restrictions / Comments :

Documentation

Guidelines (Local)

Immunosuppression in crohn's disease (Pathway 3) - December 2018.pdf

Guidelines (Local)

Immunosuppression in ulcerative colitis (Pathway 3) - December 2018.pdf

Shared Care

Azathioprine and 6MP for non-transplant indications -National shared care - update March 25

Evidence Review

Thiopurines for use in Inflammatory Bowel Disease -Evidence Review - May 2016

PAD Profile

ChemicalSubstance :

Azathioprine

Indication :

Inflammatory bowel disease

Group Name :

Keywords :

thiopurines, IBD, UC, Ulcerative Colitis, Crohn's Disease

Brand Names Include :

Imuran, Jayempi

Important Information :

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Inflammatory bowel disease

Supporting Documents :

Other Indications

Below are listed other indications that Azathioprine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Inflammatory bowel disease.

Committee Recommendations (3)

02 Jul 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

Follow link to Shared Care Principles and Communication letters Shared Care principles and Communication letters

02 Aug 23 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed a local adaptation of the National Shared Care document, in reference to the routine monitoring of CRP (rather than ESR) in primary care for inflammatory indications

05 Oct 22 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed the National Shared Care Protocol for azathioprine and mercaptopurine for patients in adult services (non- transplant indications)